SCHEMBL6264703

SCHEMBL6264703

Nc1ccc(Sc2cccs2)c(N)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 3/20 0.43
FBP1 P09467 1/20 0.42
KCNH2 Q12809 1/20 0.33
PTGS2 P35354 1/20 0.33
KDM4E B2RXH2 4/20 0.33
MAPT P10636 4/20 0.33
HPGD P15428 3/20 0.33
ALDH1A1 P00352 3/20 0.33
NPC1 O15118 3/20 0.33
HSD17B10 Q99714 3/20 0.33
TP53 P04637 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
GFER P55789 1/20 0.33
ITGB2 P05107 2/20 0.33
ICAM1 P05362 2/20 0.33
ITGAL P20701 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8308899 0.83 PDE7A (0.58) PDE7AFBP1PTGS2KDM4EMAPT
SCHEMBL9346269 0.76 ITGB2 (0.48) PDE7AKDM4EMAPTHPGDALDH1A1
SCHEMBL30565314 0.76 ITGB2 (0.48) PDE7AKDM4EMAPTHPGDALDH1A1
SCHEMBL28656445 0.73 FBP1 (0.43) PDE7AFBP1KCNH2PTGS2KDM4E
SCHEMBL2432241 0.71 FBP1 (0.68) PDE7AFBP1PTGS2KDM4EMAPT
SCHEMBL9631752 0.69 ALDH1A1 (0.61) PDE7AKDM4EMAPTHPGDALDH1A1
SCHEMBL11729689 0.69 KCNH2 (0.46) PDE7AFBP1KCNH2ALDH1A1NPC1
SCHEMBL9539495 0.69 PDE7A (0.39) PDE7AFBP1KCNH2PTGS2KDM4E
SCHEMBL29199082 0.68 PDE7A (0.61) PDE7AFBP1KDM4EMAPTALDH1A1
SCHEMBL9573601 0.67 ALDH1A1 (0.50) PDE7AKDM4EMAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005053609-A2 METHODS OF NAD+-DEPENDENT DEACETYLASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 2005-06-16 WO disclosed
WO-2005053609-A2 METHODS OF NAD+-DEPENDENT DEACETYLASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 2005-06-16 WO disclosed